Sun Pharmaceutical Industries witnessed a significant improvement in the positive media coverage during the June 2018 quarter. Regulatory approvals and encouraging earnings led the positive news coverage for Sun Pharma in the June 2018 quarter.
At the same time, the volume of negative news has also dropped sharply in the same period. As a result, the long-term news sentiment has improved towards the end of the quarter.
Moreover, the improvement in news sentiment was also reflected in the recent rally in Sun Pharma’s stock price. Net-net, the news cycle was favorable for India’s leading drug maker in the June 2018 quarter.
[Compare screen: Sun Pharma – Share Price, News Volume, and Sentiment]
FiND media coverage study for BSE 100 index companies showed a significant deterioration in the long-term news sentiment for Glenmark Pharmaceuticals, Vakrangee and fraud-hit Punjab National Bank (PNB).
These 3 companies have been receiving negative press coverage for quite some time. As a result, news sentiment 200-day moving average (DMA) for these 3 companies dipped to a 2-year low on Apr. 17, 2018.
[Image 1: Compare screen shows Sentiment 200-DMA] Read the rest of this entry »